Ivermectin In Treatment of COVID 19 Patients

M

Ministry of Health and Population, Egypt

Status

Unknown

Conditions

Covid19

Treatments

Drug: Ivermectin

Study type

Interventional

Funder types

Other

Identifiers

NCT04425707
14-2020/3

Details and patient eligibility

About

as Egypt suffered a lot during the pandemic of COVID 19 with limited drug choices, many of the patients could not acheive viral clearence with the standard module of care teh idea of introduction of new medications in the treatment protocol of COVID 19 managment. Ivermectin had shown a promising results in vitro studies and in limited in vivo studies. this clinical trial may open a new hope for COVID 19 patients as a new and cheap line of treatment

Full description

the study will compare the effect of ivermectin in comaprison and addition to the standard mode of care for the COVID 19 patients

Enrollment

100 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Asymptomatic mild cases and moderate cases proven to be infected by COVID 19 by viral RNA swap

Exclusion criteria

  • Contraindications for the drug: hypersensitivity.
  • Any medications with possible drug interactions.
  • Severe cases.
  • Any malignant condition.
  • Pregnant females.
  • Breast feeding females.
  • Any patient on the following medications: Erdafitinib- Lasmiditan- Quinidine due to potential severe drug interaction.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

100 participants in 3 patient groups

A ivermectin alone
Experimental group
Description:
ivermectin will be administarted alone to COVID 19 patients
Treatment:
Drug: Ivermectin
B standard care alone
Experimental group
Description:
standard care will be administarted alone
Treatment:
Drug: Ivermectin
C ivermectin added to standard of care
Active Comparator group
Description:
ivermectin will be administarted in adition to standard care
Treatment:
Drug: Ivermectin

Trial contacts and locations

1

Loading...

Central trial contact

ehab ah kamal, MD; noha mo asem, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems